These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 15380037)

  • 1. Biomarkers for systemic lupus erythematosus: has the right time finally arrived?
    Mittleman BB
    Arthritis Res Ther; 2004; 6(5):223-4. PubMed ID: 15380037
    [No Abstract]   [Full Text] [Related]  

  • 2. Antinuclear antibodies directed against proliferating cell nuclear antigen are not specifically associated with systemic lupus erythematosus.
    Vermeersch P; De Beeck KO; Lauwerys BR; Van den Bergh K; Develter M; Mariën G; Houssiau FA; Bossuyt X
    Ann Rheum Dis; 2009 Nov; 68(11):1791-3. PubMed ID: 19822716
    [No Abstract]   [Full Text] [Related]  

  • 3. Systemic lupus erythematosus as a cause of the pulmonary renal syndrome.
    Sewell WA; Marshall SE; Bird AG
    J Intern Med; 1996 Jul; 240(1):43. PubMed ID: 8708591
    [No Abstract]   [Full Text] [Related]  

  • 4. [Initial manifestation by cerebral vasculitis in systemic lupus erythematosus].
    Mrabet D; Meddeb N; Sahli H; Rammeh N; Sellami S
    Tunis Med; 2008 Jun; 86(6):618-9. PubMed ID: 19216467
    [No Abstract]   [Full Text] [Related]  

  • 5. DNA as a marker of cell death in systemic lupus erythematosus.
    Pisetsky DS
    Rheum Dis Clin North Am; 2004 Aug; 30(3):575-87, x. PubMed ID: 15261342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiphospholipid syndrome and systemic lupus erythematosus: are they separate entities or just clinical presentations on the same scale?
    Shoenfeld Y; Meroni PL; Toubi E
    Curr Opin Rheumatol; 2009 Sep; 21(5):495-500. PubMed ID: 19593144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of anti-nucleosome antibody in the diagnosis of systemic lupus erythematosus.
    Su Y; Jia RL; Han L; Li ZG
    Clin Immunol; 2007 Jan; 122(1):115-20. PubMed ID: 17085075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-C1q antibodies in juvenile-onset systemic lupus erythematosus.
    Jesus AA; Silva CA; Carneiro-Sampaio M; Sheinberg M; Mangueira CL; Marie SK; Liphaus BL
    Ann N Y Acad Sci; 2009 Sep; 1173():235-8. PubMed ID: 19758156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Postpartum pericardic tamponade revealing systemic lupus erythematosus].
    Ketata W; Msaad S; Feki W; Gargouri I; Ayadi H; Ayoub A
    Rev Pneumol Clin; 2009 Oct; 65(5):306-8. PubMed ID: 19878806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-chromatin and anti-C1q antibodies in systemic lupus erythematosus compared to other systemic autoimmune diseases.
    Braun A; Sis J; Max R; Mueller K; Fiehn C; Zeier M; Andrassy K
    Scand J Rheumatol; 2007; 36(4):291-8. PubMed ID: 17763207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical utility of serum diagnostic tests for rheumatic diseases].
    Mindlin A
    Rev Med Brux; 2007 Sep; 28(4):302-7. PubMed ID: 17958025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antinuclear antibodies].
    Kumagai S; Hayashi N; Kawano S
    Nihon Rinsho; 2010 Jun; 68 Suppl 6():502-5. PubMed ID: 20942114
    [No Abstract]   [Full Text] [Related]  

  • 13. Therapeutic potential (1).
    Zack DJ; Isenberg D
    Lupus; 2008 Mar; 17(3):259-61. PubMed ID: 18372373
    [No Abstract]   [Full Text] [Related]  

  • 14. Adrenomedullin--a potential disease activity marker and suppressor of nephritis activity in systemic lupus erythematosus.
    Mak A; Cheung BM; Mok CC; Leung R; Lau CS
    Rheumatology (Oxford); 2006 Oct; 45(10):1266-72. PubMed ID: 16595522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation between clinical activity and serological markers in a wide cohort of patients with systemic lupus erythematosus: an eight-year prospective study.
    Villegas-Zambrano N; Martínez-Taboada VM; Bolívar A; San Martín M; Alvarez L; Marín MJ; López-Hoyos M
    Ann N Y Acad Sci; 2009 Sep; 1173():60-6. PubMed ID: 19758133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alpha-actinin-binding antibodies in relation to systemic lupus erythematosus and lupus nephritis.
    Becker-Merok A; Kalaaji M; Haugbro K; Nikolaisen C; Nilsen K; Rekvig OP; Nossent JC
    Arthritis Res Ther; 2006; 8(6):R162. PubMed ID: 17062137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antinuclear antibodies are common in an infectious environment but do not predict systemic lupus erythematosus.
    Cainelli F; Betterle C; Vento S
    Ann Rheum Dis; 2004 Dec; 63(12):1707-8. PubMed ID: 15547107
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical utility of screening for antinuclear antibodies by enzyme immunoassay--a preliminary study.
    Divate S; Hardikar P; Bichile LS; Rajadhyaksha A
    J Assoc Physicians India; 2004 Apr; 52():290-3. PubMed ID: 15636329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytokines and their receptors as biomarkers of systemic lupus erythematosus.
    Suh CH; Kim HA
    Expert Rev Mol Diagn; 2008 Mar; 8(2):189-98. PubMed ID: 18366305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormal antinuclear antibody titers are less common than generally assumed in established cases of systemic lupus erythematosus.
    Sjöwall C; Sturm M; Dahle C; Bengtsson AA; Jönsen A; Sturfelt G; Skogh T
    J Rheumatol; 2008 Oct; 35(10):1994-2000. PubMed ID: 18785312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.